Clinical Trial Update: Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction cisplatin and capecitabine followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)

Snippet

Sponsor: The University of Hong Kong-Shenzhen Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED